As per attachment.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Norris Medicines Ltd informed BSE that its application to reclassify certain promoter shareholders into the public category has been closed by the exchange on 12.02.2026. The application was closed because the company did not pay a disputed penalty flagged by the exchange. As a result, the existing promoter/public classification of these shareholders remains unchanged, and the company's shareholding pattern is unaltered. No further action is pending on this matter.
This is a neutral to slightly negative procedural update — the failed reclassification means the promoter status stays intact and the shareholding structure is unchanged. The mention of an unpaid disputed penalty could be a minor governance red flag for investors to monitor.